FDA Approves Lyrfigtu for Previously Treated FGFR2-Positive Cholangiocarcinoma

Regulatory Approvals — FDA Approves Lyrfigtu for Previously Treated FGFR2-Positive Cholangiocarcinoma  Cure Today

Read the original at Regulatory Approvals ↗

Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. September 23, 2026.

By